Protalix BioTherapeutics, Inc. (PLX)
$2.78+2.96%Close
BUYRECOVERY · day 36
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $224M
- Beta
- 0.01
- P/E (TTM)
- 11.33
- Short % float
- 3.93%
- Days to cover
- 4.3
- SI change
- +5.6%
- 1W
- +2.58%
- 1M
- +1.83%
- vs SPY 1W
- +1.42%
- vs SPY 1M
- -1.16%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PLX?
- LOPJLB’s latest quantitative signal on Protalix BioTherapeutics, Inc. (PLX) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is PLX in?
- Protalix BioTherapeutics, Inc. (PLX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Protalix BioTherapeutics, Inc. (PLX) do?
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also…